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ABSTRACT It has recently been shown that the highly protected segments 24–34 (S2) and 83–93 (S8) of each of the two 99-mers
of human immunodeﬁciency virus type 1 protease play an essential role in the folding of the monomers, giving rise to the so-called
(postcritical) folding nucleus ((FN) minimum condensation unit ensuring folding) when they dock. This scenario received further
support from model calculations that demonstrated that the peptide p-S8, displaying an amino acid sequence identical to the
corresponding (83–93) segment of the monomer, can be used to interfere with the formation of the FN and eventually to inhibit
folding by docking the fragment 24–34. Experiments in vitro and in cells infected with ex vivo wild-type and multiresistant HIV
isolates conﬁrm that the inhibition power of p-S8 is robust. On the other hand, there is no direct evidence demonstrating the validity
of the proposedmechanism of inhibition associated with p-S8. To shed light on this question and to provide the basis for the design
of amoleculemimetic to p-S8, to be used as lead of an eventual drug against AIDS, we study, in this paper, with the help of all-atom
simulations in explicit solvent and the novel method ofmetadynamics combinedwith parallel tempering: a), the free energy and the
equilibriumstructure of eachof the peptides p-S2 andp-S8; b), the details of thedockingmechanismof the twopeptides and the free
energy associated with this process. Whereas p-S8 is found to be well structured, p-S2 is rather ﬂexible, wrapping itself around
p-S8 to give rise to the FN, which is stabilized by three particular hydrogen bonds.
INTRODUCTION
The protease of the human immunodeﬁciency virus type
1 (HIV-1-PR) is a 99-amino-acid-long homodimer (Fig. 1)
that plays an essential role in the HIV life cycle by pro-
cessing the viral polyprotein. During viral replication this
protease cuts the long polypeptide producing the compo-
nents needed for the assembly of the mature virus. For this
reason the protease is one of the main targets of acquired
immunodeﬁciency syndrome therapies.
One way to inhibit the cleaving function of HIV-1-PR is to
cap its active site. Indeed all the drugs approved so far by
FDA rely on this mechanism of competitive inhibition (1).
The main disadvantage of these inhibitors is that, under their
pressure, HIV-1-PR mutates at the active site or at a site
controlling its conformation in such a way that the drug can
no longer bind its target and the cleaving function is restored,
albeit with reduced efﬁciency. Early signs of resistance
usually appear after 6–8 months from the beginning of the
treatment (1).
Folding of the HIV-1-PR in neutral solution is a three-state
process (see, e.g., Tiana and Broglia (2)), which means that
the two monomers ﬁrst fold independently (2U/2N) and
then dock in the dimer native state (2N/N2). This scenario
is supported by sedimentation equilibrium experiments that
demonstrate a consistent population of the native monomeric
phase N (3), by NMR analysis of the protease mutated to
weaken the interactions across the monomers (4), by all-
atom simulations of the monomer in implicit solvent (5), and
by Go-model simulations of the dimer (6).
A different strategy of blocking the activity of HIV-1-PR
is based on the inhibition of the dimerization (2), relying on
the fact that the monomer is inactive, or of the folding of the
monomer itself. Broglia et al. (7) pioneered this idea of in-
hibiting the folding of the protease monomers, rather than
capping the active site of the homodimer, exploiting the knowl-
edge of the folding mechanism of single domain proteins.
Several experiments support the idea that a few fragments
of these proteins act as folding initiation sites, becoming
structured at an early stage in the folding process (for a
review, see Fersht (8)). These include hydrogen exchange
measurements, which have shown that the folding of cyto-
chrome c proceeds by assembling ﬁve folding units (9), and
nuclear magnetic resonance experiments under denaturating
conditions, which have detected partially formed native
structure, suggestive of folding initiation sites, in lysozime
(10), a-spectrin SH3 (11), staphilococcal nuclease (12), and
protein L (13).
Lattice model studies of protein folding done by Shaknovich
and co-workers (14) and more recently by Tiana and Broglia
(15) have rationalized the scenario of folding of single do-
main proteins as a hierarchic process occurring in the follow-
ing order:
1. Local elementary structures (LES) are formed. These are
short stretches of the protein containing a few hydropho-
bic, strongly interacting, and highly conserved (‘‘hot’’)
amino acids;
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2. LES dock into the (postcritical) folding nucleus (FN) of
the protein overcoming the major free energy barriers of
the folding process;
3. The remaining amino acids relax into the native confor-
mation shortly after the formation of the FN.
Model calculations (16) indicate that knowledge of the
LES of a protein can be used to interfere with its folding:
short peptides with the same sequence as a local elementary
structure (peptidic LES or p-LES) can compete with the
native LES in the formation of the FN. The protein ﬁnds it
entropically favorable to bind the p-LES instead of the native
LES because the loss of translational entropy of the p-LES
due to the docking is much less than the amount lost in the
folding of the whole protein. On the other hand calculations
suggest that most of the enthalpic contribution to the folding
process is due to the docking of the LES (15,17). The sug-
gestion of Broglia et al. (16) is that the docking of a p-LES
with its complementary LES is favored and inhibits the for-
mation of the FN, thus blocking the protein folding and its
biological activity.
This type of inhibition is not likely to be affected by
mutations of the protein: any mutation of an amino acid that
is not hot, i.e., not essential for the stability or docking of
LES, would not prevent the p-LES from binding to its
complementary LES, whereas a hot mutation would desta-
bilize the protein and make it unstable (18).
The LES of the monomer of HIV-1-PR have been iden-
tiﬁed (Fig. 1) as the fragments 24–34 (S2), 75–78 (S7), and
83–93 (S8) on the basis of a wide variety of evidence:
hierarchy of formation (7), formation temperatures of native
contacts in Go-model simulations (19), evolutionary data
(20), normal modes (21), f-value analysis (6), study of un-
folding penalties (22), and protease mutations in infected
patients (23). Go-model simulations of the HIV-1-PR to-
gether with p-S8 have conﬁrmed the inhibitory effect of the
small peptide even in the presence of mutations of the pro-
tease (7).
In vitro experiments with standard enzymatic assays in-
dicate that p-S8 inhibits the HIV-1-PR with an inhibition
constant KI ¼ 2.58 6 0.78 mM. Circular dichroism suggests
that the protein denatures upon binding with the p-LES (24).
Results on infected cells indicate that the p-LES 83–93
(or better, a more soluble variant of it not containing the
last isoleuceine (C-terminal site 93) and denoted BRU in
Rusconi et al. (25) and Cicero (26)) is not cytotoxic and
inhibits the maturation of the virus at a micromolar con-
centration.
Results in the literature (7,24–26) indicate that p-S8 con-
stitutes a promising lead for an eventual drug to ﬁght HIV,
unlikely to allow for escape mutants. Obvious disadvantages
of the (nonconventional) inhibitor is the value of its in-
hibition constant (in the micromolar level as compared to
nanomolar observed in connection with conventional, active
site-centered drugs), its length, its hydrophobicity, and its
peptidic character. A clear task lying ahead is to develop
molecules mimetic to BRU which, aside from not being
recognized by the organism, are more rigid than the original
peptide and thus display a stronger afﬁnity with the com-
plementary LES.
Detailed knowledge of the associated docking could prove
instrumental in the design of an effective mimetic molecule.
For this purpose in this work we have performed all-atom
simulations in explicit water on p-S2, p-S8, and their com-
plex. In particular, we have gained insight into the folding of
p-S8, the HIV-1-PR folding inhibitor, by reconstructing its
free energy surface (FES) using metadynamics. Finally, we
have used the combined method of metadynamics and
parallel tempering, recently proposed by Bussi et al. (27), to
obtain the free energy proﬁle associated with the docking of
the two peptides.
METHODS
Metadynamics is a method for efﬁciently computing free energies and for
accelerating rare events (28). It has already been used successfully in the
description of a number of different phenomena, including crystal structure
prediction (9,40,41), chemical reactions (29–35), protein/peptide complexes,
and ligand docking (36–39).
In this method, a set of a few collective variables (CVs) s, which are a
function of the system coordinates x, must ﬁrst be identiﬁed as suitable to
describe the process of interest: they must be able to distinguish between the
initial and ﬁnal state and they should include the main ‘‘slow’’ variable of
the system.
The dynamic in the space of the CVs is guided by the free energy of the
system plus a history-dependent potential
FGðs; tÞ ¼
Z t
0
dt9W exp ðs sðxðt9ÞÞÞ
2
2d
2
 
; (1)
sum of Gaussians of width d and weight W centered along the CVs’ tra-
jectory up to time t. Metadynamics is able to:
FIGURE 1 The two disjoint identical chains of 99 amino acids that build
the HIV-1 protease. Coordinates are taken from the sequence of the HIV-
1-PR wild-type (PDB code, 1BVG). The two local elementary structures are
colored in black (S2, the fragment 24–34) and gray (S8, the fragment 83–93).
All the ﬁgures in the article are made with the VMD package (54).
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1. Accelerate rare events; the accumulation of the hills pushes the system
out of the local minima and drives it to visit new regions of phase space.
2. Provide an unbiased estimate for the free energy surface through the
biasing potential; because limt/N  FGðs; tÞ;FðsÞ; an estimate of the
FES underlying a region explored by the time t is simply the sum of all
the accumulated hills, changed in sign (42).
As already pointed out, metadynamics requires an a priori knowledge of
the slow collective variable of the process studied and may fail when re-
constructing a free energy surface if one of these slow variables is neglected.
To overcome these limitations, metadynamics has recently been combined
with parallel tempering (27).
In the parallel tempering method (PT), M replicas of a system of N
particles at different temperatures Ti evolve independently until an exchange
of conﬁgurations between two replicas is attempted (43,44). The partition
function of the extended example of noninteracting replicas can be writ-
ten as:
Q ¼
YM
i¼1
qi
N!
Z
drNi e
biUðrNi Þ; (2)
where rNi indicates the positions of the N particles of system i at inverse
temperature KBbi, U the potential energy, and the factor qi comes from
integrating out the kinetic part of the Hamiltonian.
The probability of a swap between the ensembles j and k is:
pðj/kÞ ¼ minf1; ðbj  bkÞðUðrNj Þ  UðrNk ÞÞg: (3)
High temperature systems are more diffusive and they are able to sample
larger areas in phase space by overcoming barriers: by exchanging conﬁg-
urations with replicas at lower temperatures, PT avoids letting these ‘‘cold’’
systems be trapped in local energy minima and improves their conﬁgura-
tional sampling.
Parallel tempering does not need any a priori knowledge of the system,
but on the other hand its ability to overcome large free energy barriers is
limited and its scaling with system size is poor.
Combining metadynamics with parallel tempering means adding a bias
potential F
ðiÞ
G ðs; tÞ to each replica: the partition function (2) becomes
Q ¼
YM
i¼1
qi
N!
Z
drNi e
bi ½UðrNi Þ1F
ðiÞ
G
ðsðrNi Þ;tÞ; (4)
and the probability of a swap from replica j to k becomes pðj/kÞ ¼
minf1;Dg with:
D ¼ ðbj  bkÞ½UðrNj Þ  UðrNk Þ1bj½FðjÞG ðsðrNj Þ; tÞ
 FðjÞG ðsðrNk Þ; t1bk½FðkÞG ðsðrNk Þ; tÞ  FðkÞG ðsðrNj Þ; tÞ:
(5)
The two methods are to some extent complementary: parallel tempering
leads the system to cross moderate energy barriers on all degrees of freedom
whereas metadynamics allows high barriers on a few selected collective
variables to be overcome. The combination of the two (PTMetaD) helps in
solving the problem of ‘‘hidden’’ degrees of freedom, i.e., of identifying and
including all the slow variables of a physical phenomenon in the CVs of
metadynamics. PTMetaD has already been successfully applied to the study
of the folding of the 16-residue C-terminal fragment of protein G-B1
(b-hairpin). In the same article it has been shown that, in this case, PTMetaD
explores the phase space at least three times faster than standard parallel
tempering (27).
Recently, it has also been demonstrated that the combination of meta-
dynamics with umbrella sampling (34,45) could help in improving the
accuracy of the free energy landscape calculated with metadynamics alone.
RESULTS AND DISCUSSIONS
In this section we ﬁrst present the results of our simulations
of p-S8 and p-S2 in explicit water. These two peptides play a
dominant role in the formation of the FN, whereas the small
fragment p-S7, corresponding to residues 75–78 in the se-
quence of HIV–1–PR, is too short to be speciﬁc and most
likely only stabilizes further the nucleus already formed by
the other two LES (see Broglia et al. (7) and the deﬁnition of
open LES in Tiana and Broglia (46)). The peptides p-S2 and
p-S8 behave rather differently, as suggested by preliminary
molecular dynamics (MD) simulations. Because the former
looks poorly structured, we simply carried out a cluster anal-
ysis on a long MD simulation at room temperature. On the
other hand, the latter has an a-helix shape that suggests the
need to employ metadynamics to cross higher barriers and
reconstruct the free energy proﬁle of folding.
At the end we present an analysis of the mechanism of
interaction between p-S2 and p-S8. To obtain the free energy
landscape of this docking process, we have used, because of
the advantages described in the Methods section, the com-
bined method of metadynamics and parallel tempering.
Whenever we have reconstructed a free energy surface as
a function of a few selected CVs, we have checked the con-
vergence of our calculations and the choice of the CVs by
analyzing the distribution of the commitment probability
(47).
S2: the fragment 24–34 of HIV-1-PR
The small hydrophobic peptide p-S2 is built up of 11 resi-
dues: 24–LDTGADDTVLE–34. All the simulations were
started from the native geometry and performed in a cubic
box of 37.5 A˚ side containing 1676 water molecules. The
simulations were performed using the ORAC code (48) and
the OPLS-AA force ﬁeld, in explicit water (TIP3P model),
with multiple time step RESPA integrator (0.5 fs the inner-
most shell time step) and treating electrostatic with the
particle mesh Ewald method.
The thermalization of the system was performed in steps
of 200 ps: starting from 0 K and keeping the solute ﬁxed, we
gradually heated the system using a Berendsen thermostat
and gradually removed the constraints on the peptide. In the
last steps of the 400-ps simulation carried out at 300 K, we
left the solute free and coupled the system to a Berendsen
barostat at 1 atm to complete equilibration.
After thermalization, we ran a preliminary 5-ns-long MD
in the NVT ensemble. The peptide turned out to be un-
structured. This result was later conﬁrmed by performing
a cluster analysis on a 55-ns-long NVT MD trajectory at
300 K. We considered a structure to belong to a cluster when
its distance from any element of the cluster was ,1.5 A˚.
With this deﬁnition we found 38 clusters.
The most populated cluster is characterized by a b-turn
shape stabilized by two hydrogen bonds involving the
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carboxyl oxygen in Asp-25 and NH hydrogens of Ala-28 and
Gly-26, as shown in Fig. 2.
S8: the fragment 83–93 of HIV-1-PR
The highly hydrophobic peptide p-S8 is made up of 11 res-
idues: 83–NIIGRNLLTQI–93. The initial conﬁguration was
taken from the atomic positions of the 83–93 fragment in the
native state of the HIV-1-PR (Protein Data Bank code 1BVG
(49)). Its native conformation (from N- to C-terminal) is
made up of a piece of b-strand (stretch 83–85), an a-helix
(87–91) and a turn (92–93). It is stabilized by ﬁve hydrogen
bonds of which only the one linking the oxygen of the
carbonyl group of Gly-86 and the NH hydrogen of Leu-90 is
intrabackbone, as shown in Fig. 3. The simulation box is a
cubic cell of 37.3 A˚ lattice and contains 1649 water mol-
ecules. The thermalization protocol and all the other details
of the simulations are the same as for p-S2.
To describe the folding of this small peptide we chose two
CVs: the radius of gyration (RG) and the distance from the
native contact map (CMdist).
The ﬁrst CV is calculated over the Na a-carbon of the
peptide, whose coordinates are r~i:
RG ¼ 1
Na
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
2
+
Na
k¼1
kr~i  r~jk2
s
: (6)
Because it gives a rough measure of the size of the mol-
ecule, RG is able to discriminate between a globular state and
an extended conformation.
The contact map is a Na 3 Na symmetric matrix (M)
whose elements are deﬁned as Mij ¼ f(rij), where rij ¼
kr~i  r~jk is the distance between two Ca atoms and
f ðrÞ ¼
1 r
r0
 p
1 r
r0
 q r# rcut
0 r. rcut
;
8>>><
>>>:
(7)
is a switching function. The parameters used in this simu-
lation are: r0 ¼ 8.5 A˚, rcut ¼ 10.5 A˚, p ¼ 8 and q ¼ 10. The
second CV is the distance from the native contact map, i.e.,
from the contact map of the protein in its native conﬁguration
(M˜), deﬁned as the Frobenius distance between the two
matrices:
CMdist ¼ kM  M˜kF ¼ +
Na
i;j
ðMij  M˜ijÞ2
 !1=2
: (8)
This collective variable gives a measure of the number of
native contacts already formed.
Using these two CVs we have been able to unfold and
refold the peptide to a root mean square deviation of 0.3 A˚
from the native conﬁguration in a 6-ns simulation of pure
metadynamics. The free energy surface obtained is shown in
Fig. 4. Three regions can be distinguished.
FIGURE 2 A representative of the most populated cluster from the anal-
ysis of an NVT trajectory of the peptide p-S2. In evidence the hydrogen bonds
set among Asp-25, Ala-28, and Gly-27.
FIGURE 3 The peptide p-S8, corresponding to the fragment 83–93 of the
sequence of HIV-1 protease. In evidence the hydrogen bonds that stabilized
the native state structure.
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The basin labeled as A (CMdist ’ 0;RG ’ 5:6 A˚) in-
cludes the global minimum of the FES: it describes the native
states of the peptide in which the a-helix is formed.
Region B (CMdist . 8.0, RG . 9.0 A˚) corresponds to the
unfolded coil state of the peptide: the a-helix turns are
completely extended, all the backbone hydrogen bonds are
broken. Basin A is 7 kcal/mol more stable than basin B. The
free energy barrier for going from A to B is 9 kcal/mol.
Region C (6.0 , CMdist , 8.0, 6.5 A˚ , RG , 7.5 A˚)
corresponds to a local minimum 6 kcal/mol higher in energy
than the global one. In these conﬁgurations the helix is
broken, the peptide has the shape of a U-turn, stabilized by a
set of hydrogen bonds between the side chain of Arg-87 and
the carbonyl oxygens of Leu-89 and Thr-91.
To assess whether the collective variables chosen provide
an accurate characterization of the transition state between
the folded and unfolded conformations, we have analyzed
the distribution of the associated commitment probability
(47). We started from a guess path going from basin A to B
and, considering it as a set of N beads connected by springs,
we relaxed it on our free energy surface as in a ‘‘nudged
elastic band’’ (NEB) calculation (50,51), keeping the ex-
tremes ﬁxed. In this way we obtained a set of N points i in the
collective variables’ space along a minimum free energy path
going from the folded to the unfolded state of the peptide.
The commitment probability PAi (or P
B
i ) is the probability of
reaching basin A (or B) in short MD trajectories starting from
a conﬁguration in which the value of CV is in the neigh-
borhood of the point i.
In particular, the transition state ensemble is made up of all
the conﬁgurations for which PA ’ PB ’ 1=2: In Fig. 5 we
have plotted the commitment probability as a function of the
position along the minima free energy path from A to B and
the relative free energy value according to metadynamic
calculations.
Because the point of the path where PAi ’ PBi ’ 1=2 is
consistent within the accuracy of the calculation with the
saddle point in energy, we conclude that our choice of col-
lective variable describes the transition state correctly.
The transition state ensemble is made up of coil conﬁg-
urations with just one of the hydrogen bonds of the native
state formed, the one between the oxygen of the carbonyl
group of Leu-89 and the NH of Gln-92. This point of the FES
is 2 kcal/mol higher in energy than the coil state of the
peptide, in agreement with the energy cost of building the
ﬁrst loop of a helix as predicted by the Zimm and Bragg
theory (52). The energy difference comes from the balance
between the entropic cost of freezing the conformations of
three residues and the gain in energy arising from the for-
mation of one hydrogen bond.
Docking of the two p-LES
The two p-LES of the HIV-1-PR are small and quite ﬂexible
peptides, especially p-S2, which is far less structured than
p-S8. They are both very hydrophobic and have opposite
charges: p-S8 has a positive charge (11) due to arginine,
p-S2 is negatively charged (4) because of the presence of
three aspartic acids and one glutamic acid.
Molecular dynamic simulations of the docked conﬁgura-
tion, corresponding to most of the folding nucleus of HIV-1
protease (missing S7; 75–78), have shown that this structure
FIGURE 4 Free energy surface of p-S8 as a function of the distance
between the contact map of the native state and of the gyration radius,
evaluated only on the Ca. Isoenergy lines are drawn every 1 kcal/mol.
FIGURE 5 Committor analysis. On
the left the minima free energy path
going from basin A (native state) to
basin B (unfolded coil state), as result-
ing from NEB. Only the portion across
the transition state is shown. On the
right top panel the free energy value on
this portion of the path, as resulting
from metadynamics; on the bottom the
corresponding commitment probability,
calculated as explained in the text. The
gray stripe includes the points on the
path whose commitment probability is
close to 0.5.
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is stabilized by the three hydrogen bonds across the peptides
shown in Fig. 6. Therefore, the choice of the collective
variables for describing the interaction of these two peptides
should take into account both the hydrophobic interaction
between the peptides, which leads to the elimination of water
from the interface, and the formation of the three hydrogen
bonds hb1, hb2, and hb3, which eventually stabilize the
docked structure.
We used as our ﬁrst collective variable the distance from
the intermolecular contact map of the docked state. It is quite
similar to the one used for the study of p-S8 folding, where
instead of the a-carbons we have taken the atoms involved in
the formation of the three hydrogen bonds and the switching
function parameters have been regulated on the hydrogen
bonding distances (r0 ¼ 2.5 A˚, rcut ¼ 3.5 A˚).
This CV ranges from zero, for conﬁgurations with hb1,
hb2, and hb3 formed, to a maximum value corresponding to
a null instantaneous contact map: this maximum must be
reached when the peptides are far enough not only for the
hydrogen bonds to be broken but also for the water to be
inserted in the interface. Therefore, the parameters p and q of
the switching function in Eq. 7 must be chosen accordingly.
The second collective variable is the coordination with
water molecules of the atoms forming the three selected
hydrogen bonds and of a few others involved in the forma-
tion of secondary hydrogen bonds during the simulation. The
coordination is deﬁned as
Z ¼ +
i;j
1 rij
r0
 p
1 rij
r0
 q; (9)
where i runs over the coordinating atoms, j over all the water
molecules, rij is the distance between atom i and water
molecule j, r0 ¼ 4.0 A˚, p ¼ 8, and q ¼ 14 are the parameters
of the switching function.
With these collective variables we used the combined
method of metadynamics and parallel tempering described in
the Methods section. We prepared 64 replicas of the system
at different temperatures, starting from 300 to 600 K and
distributed in such a way as to result in an homogeneous
acceptance probability for the swaps of ’ 20%:
Exchange between the replicas was attempted every 120 fs,
whereas a Gaussian hill of 0.1 kcal/mol height was deposited
every 600 fs: after ’ 2 ns of simulation, we obtained the free
energy proﬁle shown in Fig. 7. We can distinguish four
regions in the free energy surface as a function of these
collective variables. Basin A (CMdist , 0.2, 8 , Z , 14)
corresponds to the docked conﬁguration, the global minimum
where all the three hydrogen bonds hb1, hb2, and hb3 are
formed. The second region B (0.6,CMdist, 0.8, 13, Z,
18), separated from the former by a barrier of’ 4 kcal=mol; is
a local minimum characterized by the breaking of hb1 and
water insertion between the atoms involved in this bond.
Conﬁgurations where the value of collective variables
belongs to basin C (1.4, CMdist, 1.7, 15, Z, 18) have
two hydrogen bonds broken (hb1 and hb2): they are
separated from region B by a barrier of ’ 4 kcal=mol and
from region D by ’ 2 kcal=mol; which correspond to the
breaking of the last hydrogen bond hb3. Such conﬁgurations
have all the hydrogen bonds broken and water molecules
inserted in between but still the two peptides are not sep-
arated by a layer of solvent. This basin is separated by a
barrier of ’ 4 kcal=mol from the region where the two LES
are fully solvated.
As in the case of the study of p-S8 folding, we have
analyzed the distribution of commitment probability to
FIGURE 6 The two local elementary structures docked in the folding
nucleus of HIV-1 Protease from a side view (left) and a top view (right). The
hydrogen bonds that stabilize the structure are labeled as hb1 (Ile-85–Asp-
25), hb2 (Arg-87–Ala-28), and hb3 (Ile-84–Val-32).
FIGURE 7 Free energy surface of docking between p-S8 and p-S2 as a
function of the distance from the intermolecular contact map of the docked
structure and of the coordination with water of few interfacial atoms.
Isoenergy lines are drawn every 1 kcal/mol.
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verify the correct description of the transition states across
different basins. Our choice of collective variables provides a
good description of these transition states, as shown in Fig. 8.
Because the residues 88–92 are not involved in the in-
teractions with p-S2, one could imagine designing a shorter
inhibitor, mimicking only the stretch 83–87 of p-S8. How-
ever, taking into account that shorter p-LES are as a rule less
speciﬁc and effective (16,46), the possibility of shortening
this peptide without compromising the interactions with the
complementary local elementary structure S2 remains an
open question. An experiment of activity of the shorter pep-
tide, similar to the one reported in Broglia et al. (24), could
shed light into this important question and serve as a test of
the proposed mechanism of inhibition.
CONCLUSIONS
In this work we have studied the properties of the small
peptide p-S8, which is thought to substitute the LES S8 in the
formation of the folding nucleus of the HIV-1 protease,
inhibiting the folding of the monomers and thus of the whole
protein.
The fragment p-S8 turned out to be very stable, with an
a-helix shape, its stabilization energy being ’ 9 kcal=mol:
This result suggests that this segment of the protease, so
stable in isolation, could form independently of the rest of
the protein: this is a crucial requirement for folding to be a
hierarchical process (53). On the other hand, we have shown
that the peptide p-S2, corresponding to the fragments 24–34
of HIV-1-PR, is much more ﬂexible and substantially un-
structured.
We have studied the docking of the two peptides by means
of the combined method of metadynamics and parallel tem-
pering, using a measure of the water present in the interface
and the formation of hydrogen bonds across the molecules as
order parameters. This process does not conﬁgure as a docking
between two rigid molecules, but rather as a wrapping of a
ﬂexible peptide (p-S2) around a rigid structure (p-S8).
FIGURE 8 Committor analysis. In
the ﬁrst line the transition from basin A
to B, in the second from B to C, and in
the last line the transition from C to D.
On the left panel in each line is the
portion of the minima free energy path
across the transition state; (right top
panel) the free energy value on this
portion of the path, as resulting from
metadynamics, (bottom) the correspond-
ing commitment probability. The gray
stripe includes the points on the path
whose commitment probability is close
to 0.5.
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Although this picture can be somewhat altered in the case in
which p-S8 acts on the whole protein, and the segment S2
belongs to the HIV-1-PR monomer, pilot calculations of
such a situation do not indicate much change from the p-S2
and p-S8 situation. We have observed that p-S2 and p-S8
recognize each other forming a rather stable complex, a fact
that lends strong support to the (postcritical) FN found in Go-
model simulations. We have demonstrated that this complex
is stabilized by three particular hydrogen bonds, none of
them involving the terminal a-helix of p-S8.
Furthermore, the insight obtained from the results of the
calculations reported above is likely to help the design of a
synthetic molecule that inhibits the folding of HIV-1-PR by
mimicking the activity of the peptide p-S8.
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